Literature DB >> 7381453

CNS tryptamine metabolism in hepatic coma.

S N Young, S Lal.   

Abstract

Lumbar CSF indoleacetic acid (IAA) was higher in patients with cirrhosis of the liver than in controls. It was also higher in CSF of patients in coma than in those with hepatic cirrhosis but not in coma. There was a strong correlation (r = 0.89, p less than 0.01) between the grade of hepatic coma and CSF IAA. These data indicate that there is an association between elevated CNS tryptamine metabolism and hepatic coma. How far changes in the metabolism of tryptamine and other trace amines are relevant to the induction of hepatic coma or are simply a reflection of advanced liver dysfunction is unclear.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381453     DOI: 10.1007/bf01250597

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  26 in total

1.  The effect of sodium glutamate on hepatic coma.

Authors:  L T WEBSTER; C S DAVIDSON
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

2.  Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration.

Authors:  S N Young; S Lal; T L Sourkes; F Feldmuller; A Aronoff; J B Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-04       Impact factor: 10.154

3.  Cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid, lactic acid, and pH before and after probenecid in hepatic coma.

Authors:  S Lal; A Aronoff; E Garelis; T L Sourkes; S N Young; C E de la Vega
Journal:  Clin Neurol Neurosurg       Date:  1975-12       Impact factor: 1.876

4.  Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline.

Authors:  M Asberg; L Bertilsson; D Tuck; B Cronholm; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1973 Mar-Apr       Impact factor: 6.875

5.  Indoleamine metabolism in rat brain studied through measurements of tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in cerebrospinal fluid.

Authors:  S N Young; G M Anderson; W C Purdy
Journal:  J Neurochem       Date:  1980-02       Impact factor: 5.372

6.  The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid.

Authors:  S N Young; G M Anderson; S Gauthier; W C Purdy
Journal:  J Neurochem       Date:  1980-05       Impact factor: 5.372

7.  Liquid chromatographic-fluorometric system for the determination of indoles in physiological samples.

Authors:  G M Anderson; W C Purdy
Journal:  Anal Chem       Date:  1979-02       Impact factor: 6.986

8.  Urinary excretion of dimethyltryptamine in liver disease.

Authors:  S A Checkley; M C Oon; R Rodnight; M P Murphy; R S Williams; J L Birley
Journal:  Am J Psychiatry       Date:  1979-04       Impact factor: 18.112

9.  Influence of phenylethanolamine on octopamine plasma determination in hepatic encephalopathy.

Authors:  L Capocaccia; C Cangiano; A Cascino; V Calcaterra; P Cardelli; F Rossi Fanelli
Journal:  Clin Chim Acta       Date:  1979-05-02       Impact factor: 3.786

10.  Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma.

Authors:  A R Smith; F Rossi-Fanelli; V Ziparo; J H James; B A Perelle; J E Fischer
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

View more
  9 in total

Review 1.  Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 3.  Hepatic encephalopathy: a dynamic or static condition.

Authors:  Charmaine A Stewart; Jane Cerhan
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

4.  Tryptophan metabolism in D-galactosamine-induced liver injury.

Authors:  Y Mizoguchi; C Kodama; M Sakai; Y Sakagami; K Kobayashi; S Morisawa; S Yamamoto; J Yamada
Journal:  Gastroenterol Jpn       Date:  1988-10

5.  Hypothalamic-pituitary dopaminergic function in hepatic failure in man.

Authors:  S Lal; M Oravec; A Aronoff; M E Kiely; H Guyda; S Solomon; N P Nair
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

6.  Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid.

Authors:  S N Young; S Gauthier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

Review 7.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

8.  Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  M Bergeron; T A Reader; G P Layrargues; R F Butterworth
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

9.  Hypoxia Routes Tryptophan Homeostasis Towards Increased Tryptamine Production.

Authors:  Soumya R Mohapatra; Ahmed Sadik; Suraj Sharma; Gernot Poschet; Hagen M Gegner; Tobias V Lanz; Philippe Lucarelli; Ursula Klingmüller; Michael Platten; Ines Heiland; Christiane A Opitz
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.